ACRV vs CHRW · $65.1M cap vs P/E 37, rev $8.95B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
ACRV currently screens at market cap $65.1M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the ACRV and CHRW stock pages for the full models.
Not investment advice.